References
- Karhadkar TR, Pilling D, Cox N, Gomer RH. Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model. Sci Rep. 2017;7(1):15069. doi:10.1038/s41598-017-15198-8.
- Nance T, Smith KS, Anaya V, et al. Transcriptome analysis reveals differential splicing events in IPF lung tissue. PLoS One. 2014;9(3):e97550.
- Reyfman PA, Walter JM, Joshi N, et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199(12):1517–1536. doi:10.1164/rccm.201712-2410OC.
- Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18(24):5294–5299. doi:10.1021/bi00591a005.
- Bubner B, Gase K, Baldwin IT. Two-fold differences are the detection limit for determining transgene copy numbers in plants by real-time PCR. BMC Biotechnol. 2004;4(1):14.
- Karhadkar TR, Chen W, Gomer RH. Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3−/−) mice. Am J Physiol-Lung Cell Mol Physiol. 2020;318(1):L165–L179. doi:10.1152/ajplung.00275.2019.
- Pilling D, Buckley CD, Salmon M, Gomer RH. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol. 2003;171(10):5537–5546. doi:10.4049/jimmunol.171.10.5537.
- Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res. 1998;243(2):359–366. doi:10.1006/excr.1998.4172.
- Giard DJ, Aaronson SA, Todaro GJ, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51(5):1417–1423. doi:10.1093/jnci/51.5.1417.
- Rodriguez-Walker M, Daniotti JL. Human sialidase Neu3 is S-Acylated and behaves like an integral membrane protein. Sci Rep. 2017;7(1):4167. doi:10.1038/s41598-017-04488-w.
- Downs CA, Kreiner LH, Trac DQ, Helms MN. Acute effects of cigarette smoke extract on alveolar epithelial sodium channel activity and lung fluid clearance. Am J Respir Cell Mol Biol. 2013;49(2):251–259. doi:10.1165/rcmb.2012-0234OC.
- Upton PD, Davies RJ, Tajsic T, Morrell NW. Transforming growth factor-beta(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3. Am J Respir Cell Mol Biol. 2013;49(6):1135–1145. doi:10.1165/rcmb.2012-0470OC.
- Panda AC, Martindale JL, Gorospe M. Polysome fractionation to analyze mRNA distribution profiles. Bio Protoc. 2017;7(3):e3176.
- Yang WY, Wilson HD, Velagapudi SP, Disney MD. Inhibition of non-ATG translational events in cells via covalent small molecules targeting RNA. J Am Chem Soc. 2015;137(16):5336–5345. doi:10.1021/ja507448y.
- Beauchamp RD, Sheng HM, Alam T, Townsend CM, Jr., Papaconstantinou J. Posttranscriptional regulation of albumin and alpha-fetoprotein messenger RNA by transforming growth factor-beta 1 requires de novo RNA and protein synthesis. Mol Endocrinol. 1992;6(11):1789–1796. doi:10.1210/me.6.11.1789.
- Liu C, Wallace K, Shi C, et al. Post-transcriptional stimulation of transforming growth factor beta 1 mRNA by TGF-beta 1 treatment of transformed human osteoblasts. J Bone Miner Res. 1996;11(2):211–217. doi:10.1002/jbmr.5650110210.
- Lopez-Diaz FJ, Gascard P, Balakrishnan SK, et al. Coordinate transcriptional and translational repression of p53 by TGF-beta1 impairs the stress response. Mol Cell. 2013;50(4):552–564.
- Gong J, Ammanamanchi S, Ko TC, Brattain MG. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Cancer Res. 2003;63(12):3340–3346.